The Joint Misses Q1 Earnings Estimates on Rising Expenses

Stock Information for Fennec Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Fennec Pharmaceuticals Inc.

The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California
Give Your Back a Break this Holiday with The Joint Chiropractic's "Back Friday Deals"
The Joint Corp. Reports Third Quarter 2025 Financial Results
The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program
The Joint Corp. to Host Conference Call on Thursday, November 6th to Discuss Third Quarter 2025 Results
The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List
The Joint Chiropractic Debuts in Delaware
The Joint Corp. Names Debbie L. Gonzalez Chief Marketing Officer

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.